Episode 64: Emily Sims, MD, Pediatric Endocrinologist and Assistant Professor of Pediatrics at Indiana University

TheSugarScience Podcast- curating the scientific conversation in type 1 diabetes

English - March 11, 2021 17:00 - 17 minutes - 24.2 MB
Science Business Non-Profit Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Episode 63: Alex Cogdill, PhD, Director of Business Development and Corporate Strategy at Immunai

Next Episode: Episode 64: Laia Gómez Muñoz, PhD student in Immunology, Germans Trias i Pujol Research Institute (IGTP)

In this episode, Dr. Emily Sims joins us to discuss her research focused on diabetes risk factors and treatments to predict or slow diabetes progression. Tune in to learn more about her recent publication on teplizumab, titled "Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals".

Click here to read the full paper.